Cell-to-cell variability within a clonal population, also known as non-genetic heterogeneity, has created significant challenges for intervening with diseases such as cancer. While non-genetic heterogeneity can arise from the variability in the expression of specific genes, it remains largely unclear whether and how clonal cells could be heterogeneous in the expression of the entire transcriptome. Here, we showed that gene transcriptional activity is globally modulated in individual cancer cells, leading to non-genetic heterogeneity in the global transcription rate. Such heterogeneity contributes to cell-to-cell variability in transcriptome size and displays both dynamic and static characteristics, with the global transcription rate temporally modulated in a cell-cycle-coupled manner and the time-averaged rate being distinct between cells and heritable across generations. Additional evidence indicated the role of ATP metabolism in this heterogeneity, and suggested its implication in intrinsic cancer drug tolerance. Collectively, our work shed light on the mode, mechanism, and implication of a global but often hidden source of non-genetic heterogeneity.
Keyphrases
- single cell
- rna seq
- genome wide
- cell cycle
- copy number
- induced apoptosis
- poor prognosis
- cell therapy
- transcription factor
- cell proliferation
- gene expression
- papillary thyroid
- emergency department
- stem cells
- cell cycle arrest
- mesenchymal stem cells
- oxidative stress
- signaling pathway
- pi k akt
- heat stress
- squamous cell
- binding protein
- bioinformatics analysis